Sign Up
Stories
Biotech Collaboration Enhances Sector Solutions
Share
Advancements in Gene Editing and Cancer ...
Biopharma Breakthroughs and Safety Advan...
Biotech Collaboration Enhances CRISPR In...
4DMT Presents Positive Interim Data
Biotech Collaboration for Industry Innov...
Biotech Collaboration for Innovative Sol...
Overview
API
Modalis Therapeutics partners with Ginkgo Bioworks, leveraging CRISPR technology for diverse sectors like cell therapy and agriculture.
Ask a question
How does this collaboration reflect broader trends in biotechnology and synthetic biology partnerships?
How might the partnership between Modalis and Ginkgo Bioworks impact the development of new therapies?
What potential breakthroughs could arise from the application of CRISPR technology in agriculture and food sectors?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage